Baker Avenue Asset Management’s ResMed RMD Stock Holding History

Baker Avenue Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Buy	1,828 +581	+47%	+$120K	0.01%	625
2026 Q1	$280K	Buy	1,247 +404	+48%	+$101K	0.01%	626
2025 Q4	$203K	Sell	843 -175	-17%	-$44.8K	﹤0.01%	610
2025 Q3	$279K	Buy	+1,018	New	+$278K	0.01%	495
2023 Q4	–	Sell	-57	Closed	-$8.43K	–	1249
2023 Q3	$8.43K	Buy	57 +36	+171%	+$6.51K	﹤0.01%	803
2023 Q2	$4.59K	Sell	21 -2	-9%	-$446	﹤0.01%	868
2023 Q1	$5.04K	Buy	23 +2	+10%	+$434	﹤0.01%	869
2022 Q4	$4.37K	Buy	+21	New	+$4.61K	﹤0.01%	838

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Baker Avenue Asset Management's RMD Position: Q2 2026 in Review

Baker Avenue Asset Management increased its ResMed (RMD) stake by 47% in Q2 2026, buying an estimated $120K and bringing the position to 1,828 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #625.

Baker Avenue Asset Management first reported a position in RMD in Q4 2022 and has held it in 8 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Baker Avenue Asset Management held 1,828 shares of ResMed worth $356K as of Q2 2026.
Baker Avenue Asset Management bought 581 ResMed shares in Q2 2026, an estimated $120K.
ResMed made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #625 holding.
Baker Avenue Asset Management first reported a position in ResMed in Q4 2022 and has held it in 8 quarters since.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.